en

PRODUCT DETAIL

Razarxo 15 mg filmom obalené tablety

Code 7482E
MA number 16/0233/24-S
Product Form: tbl flm 28x15 mg (blis.PVC/PVDC/PVC//Al - kalend.bal.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: TAD Pharma GmbH, Germany
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AF Direct factor Xa inhibitors
B01AF01 Rivaroxaban
Shelf life: 36
Container: blister PVC/PVDC/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 20.09.2024
Validity: 20.09.2029
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Razarxo 15 mg; 20 mg filmom obalené tablety_09_2024.pdf  
SPC: SPC_Razarxo 15 mg filmom obalené tablety_09_2024.pdf  
Safety feature Yes
Data update: 23.09.2024
eu-flag.png sk-flag.png